Pfizer Inc and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine to the US Food and Drug Administration to include adolescents aged 12 to 15.
Pfizer files for full FDA approval of COVID-19 vaccine in adolescents
